• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除与消融治疗早期肝细胞癌:回顾性队列分析。

Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.

机构信息

Department of Surgery, Massachusetts General Hospital, Boston, MA, 02114, United States; Newton Wellesley Hospital, Newton, MA, 02462, United States.

Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, 75390, United States.

出版信息

Am J Surg. 2019 Jul;218(1):157-163. doi: 10.1016/j.amjsurg.2018.12.067. Epub 2019 Jan 3.

DOI:10.1016/j.amjsurg.2018.12.067
PMID:30635211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6571152/
Abstract

BACKGROUND

The most appropriate treatment for early-stage hepatocellular carcinoma (HCC) remains unclear. This study compared the association of resection versus ablation with overall survival (OS) in patients with early-stage HCC.

METHODS

Using the National Cancer Database (NCDB), patients diagnosed with stage I/II HCC between 2004 and 2014 were identified. Cox analysis was used to determine predictors of OS.

RESULTS

We identified 53,161 patients, of whom 15.9% underwent ablation and 14.5% underwent resection. Patients with fewer comorbidities, larger tumors, and private insurance were more likely to undergo resection. Resection was associated with significantly improved OS compared to ablation (HR 0.58, 95% CI 0.54-0.61, p < 0.001), at all tumor sizes (p < 0.05) and any degree of liver fibrosis (p < 0.05).

CONCLUSIONS

Resection of HCC tumors of all sizes and any degree of underlying fibrosis was associated with significantly improved OS compared with ablation. There was pronounced variability in the use of ablation versus resection for early-stage HCC.

SUMMARY

This study found that patients with early-stage hepatocellular carcinoma (HCC) have improved overall survival (OS) after surgical resection, compared to ablation, at all tumor sizes and any extent of liver disease. There were also marked variations in treatment patterns for early-stage HCC.

摘要

背景

早期肝细胞癌(HCC)的最佳治疗方法仍不清楚。本研究比较了手术切除与消融治疗早期 HCC 患者的总生存期(OS)。

方法

利用国家癌症数据库(NCDB),确定了 2004 年至 2014 年间诊断为 I/II 期 HCC 的患者。采用 Cox 分析确定 OS 的预测因素。

结果

共纳入 53161 例患者,其中 15.9%接受消融治疗,14.5%接受手术切除。合并症较少、肿瘤较大、有私人保险的患者更倾向于接受手术切除。与消融治疗相比,手术切除显著改善了 OS(HR 0.58,95%CI 0.54-0.61,p < 0.001),且在所有肿瘤大小(p < 0.05)和任何程度的肝纤维化(p < 0.05)均如此。

结论

与消融治疗相比,所有大小的 HCC 肿瘤和任何程度的基础纤维化的手术切除与显著改善的 OS 相关。早期 HCC 的消融与手术切除的使用存在明显差异。

总结

本研究发现,与消融治疗相比,早期 HCC 患者的手术切除可显著改善 OS,且在所有肿瘤大小和任何程度的肝病中均如此。早期 HCC 的治疗模式也存在显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6498/6571152/0c9931dc742d/nihms-1525400-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6498/6571152/26735db7990d/nihms-1525400-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6498/6571152/0c9931dc742d/nihms-1525400-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6498/6571152/26735db7990d/nihms-1525400-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6498/6571152/0c9931dc742d/nihms-1525400-f0002.jpg

相似文献

1
Surgical resection versus ablation for early-stage hepatocellular carcinoma: A retrospective cohort analysis.手术切除与消融治疗早期肝细胞癌:回顾性队列分析。
Am J Surg. 2019 Jul;218(1):157-163. doi: 10.1016/j.amjsurg.2018.12.067. Epub 2019 Jan 3.
2
Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.射频消融与手术切除治疗肝细胞癌:来自美国国家癌症数据库的当代治疗趋势和结果。
Eur Radiol. 2019 May;29(5):2679-2689. doi: 10.1007/s00330-018-5902-4. Epub 2018 Dec 17.
3
Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.手术切除与消融治疗直径≤3cm肝细胞癌的基于人群的分析。
HPB (Oxford). 2015 Oct;17(10):896-901. doi: 10.1111/hpb.12446. Epub 2015 Jul 31.
4
Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.社会经济学、手术治疗与早期肝细胞癌生存率的关联
J Surg Res. 2017 Apr;210:253-260. doi: 10.1016/j.jss.2016.11.042. Epub 2016 Nov 30.
5
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.手术切除与射频消融治疗巴塞罗那临床肝癌分期非常早期/早期肝癌患者的生存比较。
J Hepatol. 2012 Feb;56(2):412-8. doi: 10.1016/j.jhep.2011.05.020. Epub 2011 Jul 12.
6
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.白蛋白-胆红素分级预测肝癌极早期/早期行肝切除术与射频消融术的疗效。
Surgeon. 2018 Jun;16(3):163-170. doi: 10.1016/j.surge.2017.07.003. Epub 2017 Aug 12.
7
Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma.一线射频消融术与手术切除及肝移植治疗早期肝细胞癌患者的疗效比较
Cancer. 2017 May 15;123(10):1817-1827. doi: 10.1002/cncr.30531. Epub 2017 Jan 13.
8
Thermal Ablation versus Surgical Resection for the Treatment of Stage T1 Hepatocellular Carcinoma in the Surveillance, Epidemiology, and End Results Database Population.监测、流行病学和最终结果数据库人群中热消融与手术切除治疗T1期肝细胞癌的比较
J Vasc Interv Radiol. 2017 Mar;28(3):325-333. doi: 10.1016/j.jvir.2016.11.001. Epub 2017 Jan 7.
9
Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.射频消融与手术治疗血管周围型肝细胞癌:长期疗效的倾向评分分析。
J Hepatol. 2018 Jul;69(1):70-78. doi: 10.1016/j.jhep.2018.02.026. Epub 2018 Mar 8.
10
Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.纤维化评分影响肝癌(HCC)切除术后的生存:监测、流行病学和最终结果(SEER)数据库分析。
Asian J Surg. 2018 Nov;41(6):551-561. doi: 10.1016/j.asjsur.2018.01.001. Epub 2018 Feb 14.

引用本文的文献

1
Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation.美国早期肝癌患者接受手术切除或消融治疗的真实世界治疗模式及结果
Hepat Oncol. 2025 Dec;12(1):2530377. doi: 10.1080/20450923.2025.2530377. Epub 2025 Jul 24.
2
Influence of Obesity and Fluid Balance on Operative Outcomes in Hepatic Resection.肥胖和液体平衡对肝切除手术结局的影响
J Pers Med. 2022 Nov 13;12(11):1897. doi: 10.3390/jpm12111897.
3
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.

本文引用的文献

1
A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma.一项比较射频消融与肝切除术治疗肝细胞癌的前瞻性随机研究。
Ann Surg Treat Res. 2018 Feb;94(2):74-82. doi: 10.4174/astr.2018.94.2.74. Epub 2018 Jan 30.
2
Women receive more inpatient resections and ablations for hepatocellular carcinoma than men.女性因肝细胞癌接受住院切除和消融治疗的人数比男性多。
World J Hepatol. 2017 Dec 28;9(36):1346-1351. doi: 10.4254/wjh.v9.i36.1346.
3
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.
LSD1 和 LSD2 在胃肠道系统癌症中的作用:最新进展。
Biomolecules. 2022 Mar 17;12(3):462. doi: 10.3390/biom12030462.
4
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.血管包绕肿瘤簇对于复发性早期肝细胞癌治疗优化的预测价值。
Cancer Med. 2021 Aug;10(16):5466-5474. doi: 10.1002/cam4.4102. Epub 2021 Jul 1.
5
Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes.单发性肝细胞癌的手术切除与经皮消融治疗:探讨肝脏影像报告和数据系统(Li-RADS)分类对肿瘤学结局的影响
Cancers (Basel). 2021 Apr 1;13(7):1671. doi: 10.3390/cancers13071671.
6
Identification of predictive factors in hepatocellular carcinoma outcome: A longitudinal study.肝细胞癌预后预测因素的识别:一项纵向研究。
Oncol Lett. 2020 Jul;20(1):765-773. doi: 10.3892/ol.2020.11581. Epub 2020 Apr 28.
7
Curative-Intent Therapies in Localized Hepatocellular Carcinoma.局限性肝细胞癌的治愈性治疗。
Curr Treat Options Oncol. 2020 Mar 19;21(4):31. doi: 10.1007/s11864-020-0725-3.
8
Identification of Potentially Therapeutic Target Genes of Hepatocellular Carcinoma.肝细胞癌潜在治疗靶点的鉴定。
Int J Environ Res Public Health. 2020 Feb 7;17(3):1053. doi: 10.3390/ijerph17031053.
经皮治疗肝细胞癌:现状与创新。
J Hepatol. 2018 Apr;68(4):783-797. doi: 10.1016/j.jhep.2017.10.004. Epub 2017 Oct 13.
4
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.2015 年全球疾病负担研究:1990 年至 2015 年全球、区域和国家一级原发性肝癌及相关病因负担。
JAMA Oncol. 2017 Dec 1;3(12):1683-1691. doi: 10.1001/jamaoncol.2017.3055.
5
Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function.对于肝功能良好的肝细胞癌患者,原位肝移植相较于肝切除术具有生存优势。
Surgery. 2017 Nov;162(5):1032-1039. doi: 10.1016/j.surg.2017.07.017. Epub 2017 Sep 1.
6
Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.医疗补助计划参保者及未参保的肝细胞癌患者肿瘤分期更高,接受治疗的可能性更低。
J Clin Gastroenterol. 2018 May/Jun;52(5):437-443. doi: 10.1097/MCG.0000000000000859.
7
Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.社会经济学、手术治疗与早期肝细胞癌生存率的关联
J Surg Res. 2017 Apr;210:253-260. doi: 10.1016/j.jss.2016.11.042. Epub 2016 Nov 30.
8
Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.手术切除与消融治疗直径≤3cm肝细胞癌的基于人群的分析。
HPB (Oxford). 2015 Oct;17(10):896-901. doi: 10.1111/hpb.12446. Epub 2015 Jul 31.
9
Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2  cm in a Propensity Score Model.倾向评分模型中,手术切除与射频消融治疗直径≤2cm的单发肝细胞癌的比较
Ann Surg. 2016 Mar;263(3):538-45. doi: 10.1097/SLA.0000000000001178.
10
Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies.经皮射频消融与手术切除治疗小肝细胞癌的疗效和安全性:23 项研究的荟萃分析。
J Cancer Res Clin Oncol. 2015 Jan;141(1):1-9. doi: 10.1007/s00432-014-1708-1. Epub 2014 Jun 3.